The objective of this study was to determine the effectiveness of screening and successful treatment of methicillin-resistant Staphylococcus aureus (MRSA) colonisation in elective orthopaedic patients on the subsequent risk of developing a surgical site infection (SSI) with MRSA.
The incidence of methicillin-resistant Staphylococcus aureus (MRSA) colonisation is increasing in hospitals in the United Kingdom, with around 5.3% of orthopaedic patients being positive on admission.
1,2 Colonisation with MRSA and methicillin-sensitive Staph. aureus (MSSA) has been shown to be associated with an increased risk of subsequent surgical site infection (SSI). 3, 4 The mortality risk associated with MRSA infection is double that of MSSA infection, and consequently, MRSA has become a major issue for hospitals. 5 MRSA screening is common for patients undergoing elective orthopaedic procedures, and a decrease in the incidence of subsequent MRSA infection has been demonstrated. 6, 7 In the elective setting, patients with positive screening can be treated in an attempt to reduce the risk of post-operative MRSA SSIs. The role of screening in the wider hospital setting is controversial. A recent study 8 argues that the justification for universal screening is unclear, and that the Department of Health's mandatory MRSA screening policy, introduced in April 2009, breaches ethical guidelines. Most people included for screening gained little benefit; some may even have experienced adverse consequences from delays in treatment or being treated in isolation. 8 It has been
shown that the risk of developing an MRSA SSI post-operatively in trauma patients colonised with MRSA is 2.5 times greater than that of the normal population. 9 However, the risk of developing an MRSA SSI in elective orthopaedic patients has yet to be ascertained.
The aim of our study was to determine the risk of developing an MRSA SSI postoperatively in elective orthopaedic patients who were previously colonised with MRSA, and who had received successful pre-operative eradication treatment.
Patients and Methods
Since January 2005, all elective orthopaedic patients admitted to the Glasgow Royal Infirmary have undergone a pre-operative assessment which includes screening of the nose, throat and groin for MRSA colonisation. All positive cases are entered into a specific departmental MRSA database and undergo a five-day programme for topical eradication, prior to retesting by their general practitioner. The programme was as follows: nasal eradication with mupirocin 2% three times daily for five days, or fusidic acid with polymyxin for mupirocinresistant MRSA; skin decolonisation with Clinisan advance bodywash daily for five days, with shampoo once or twice in five days. Treatment is stopped two days before re-screening. Only when patients are MRSA-negative can they proceed to surgery. Patients must be admitted for operation within three months of a negative screen, otherwise re-screening is required.
We retrospectively analysed all orthopaedic elective patients aged 16 years and older screened for MRSA between January 2005 and April 2008. In those colonised with MRSA, we determined the site of colonisation, eradication prior to surgery, risk factors for colonisation, prophylactic antibiotics used during the operation, and the subsequent development of an SSI in the year after surgery. It has been shown that certain groups are at a higher risk of MRSA colonisation, such as young males, those previously colonised with MRSA, and those living in residential or nursing homes. 10 For this study, we classified these groups as high risk. We considered those who live in their own home, those with no recent hospital admission and no previous history of MRSA colonisation, as low risk. Deep SSI was defined according to the World Health Organisation classification 11 as infection involving deep tissues, such as fascia or muscle, and including infection involving superficial and deep incision sites. Superficial SSI was defined as infection involving only the skin and subcutaneous tissues.
We compared the rates of SSI with the MRSA-negative population admitted to our elective orthopaedic unit during the same period. Patients undergoing surgery as a daycase were excluded. Statistical analysis. Continuous data were tested for normality using the Anderson-Darling test. Comparisons between groups were performed using t-tests or MannWhitney tests. Categorical variables were investigated between groups using chi-squared tests. Confidence intervals were computed for rates using the normal approximation where rates were sufficiently high for the assumptions to hold, otherwise Exact methods were used. All analyses were done using Minitab version 15 (Minitab Inc., State College, Pennsylvania) at a significance level of 5%.
Results
Between January 2005 and April 2008 there were 5933 admissions for elective orthopaedic in-patient surgery. The mean age of the patients was 60 years (22 to 97) and the male to female ratio was 1:1.2. MRSA colonisation was positive in 108 patients (1.8%) at the initial pre-operative assessment (Fig. 1) . This group had a mean age of 66 years (23 to 93), with a male to female ratio of 1:1.4. They were significantly older than the negative group (p < 0.001, Mann-Whitney test and confidence interval (CI)) but there was no significant difference in gender (p = 0.421, MannWhitney test and CI).
All MRSA-colonised patients were treated topically and 107 of 108 (99.1%) were confirmed as MRSA-negative following re-swabbing. Of the 108, 15 patients (13.9%) were removed from the waiting list because of other health problems, and 93 (86.1%) underwent the planned elective surgery. One of these patients remained MRSA-positive at the time of the planned operation and was removed from the study. Another who died post-operatively and one who did not attend for follow-up were also excluded, leaving 90 patients for analysis.
Our standard antibiotic prophylactic policy at the time was to administer cefuroxime routinely to any patient with a negative MRSA screen. The rationale for this was to preserve antibiotic agents against MRSA for treatment rather than for prophylaxis. A total of 68 patients (75.6%) were given prophylactic antibiotics peri-operatively, 16 (17.8%) did not receive antibiotics, and in six cases (6.7%) no information regarding prophylactic antibiotics was available. Of the 68 patients who were given antibiotics, 65 (95.6%) received cefuroxime and three (4.4%) were given vancomycin. Those who did not receive antibiotics underwent procedures where it was not routine practice to administer antibiotics prophylactically.
Relatively few patients previously colonised with MRSA were in the high-risk groups. A total of 77 (85.6%) patients lived in their own home, and only six (6.7%) lived in a residential or nursing home. One (1.1%) had a previous MRSA infection and another (1.1%) a previous hospital admission for trauma.
All patients in the analysed group returned for assessment up to one year post-operatively. Six of 90 (6.7%) had an SSI within this time. There was deep sepsis in four patients (4.4%) and superficial infection in two (2.2%) ( Table I ).
The mean age of patients with a post-operative SSI was 67 years (37 to 93), with a higher mean age of 77 years (62 to 93) for those with an MRSA SSI. Despite the age difference between the groups, the difference in infection rate could not be explained by this factor alone.
Deep sepsis rates in lower-limb joint replacements were high in the patients previously colonised with MRSA, with two SSIs of 27 (7.4%) total hip replacements (THR) and two of 29 (6.9%) total knee replacements (TKR). This is a statistically significant difference from the MRSA-negative control group, which had a deep sepsis rate of 1.12% for THR and 0.4% for TKR over the same period (Tables II  and III) .
Discussion
Our study indicates that MRSA-colonised patients tend to be older but are otherwise of a similar demography to the patients who have not been colonised. These findings are consistent with a recent study of risk factors for MRSA colonisation. 12 Our cohort is not representative of all orthopaedic patients, as younger, healthier adults tend to be admitted for day surgery and were not included.
Our study is the first to analyse the effect of MRSA colonisation after 'successful' eradication on the risk of subsequent SSI in elective orthopaedic patients. A previous study of trauma admissions showed that MRSA-colonised patients are at increased risk of developing an MRSA SSI, 9 as have studies from intensive care units and general hospitals. 13, 14 Unlike elective surgery, these acute settings do not allow for eradication therapy before surgery. Our study indicates that patients colonised with MRSA at their pre-operative assessment are at increased risk of developing an MRSA SSI, despite 'effective' eradication therapy, and that this risk is significant for patients undergoing total hip and knee replacement. Our study also indicates that where infection develops in this cohort, MRSA is the most likely organism.
Surgical site infection can have a major impact on morbidity in patients undergoing arthroplasty. In our centre, the overall rates of SSI in patients with negative screens for MRSA were 1.1% for THR and 0.4% for TKR, respectively. These rates compare favourably with published data. 15, 16 We therefore conclude that the data presented here in relation to patients screening positive for MRSA cannot be explained by poor general infection control.
Our study raises issues regarding antibiotic prophylaxis in orthopaedic surgery. Current guidelines indicate that orthopaedic operations involving implants are high-risk and prophylactic antibiotics should be used. These should cover all expected pathogens for that site, and cefuroxime should be used in non-MRSA carriers and teicoplanin in MRSA carriers. 17 Cefuroxime was used as prophylaxis in all patients in this study, as all were subsequently screened negative. This decision was based on the perhaps naive assumption that a negative screen for MRSA indicated that patients were fully decolonised. It is not clear whether the use of vancomycin or teicoplanin would have reduced the risk of subsequent MRSA SSIs in these patients. The policy for antibiotic prophylaxis in our unit has been changed to teicoplanin for all previously MRSA-colonised patients, regardless of whether eradication had been achieved by the time of surgery. Indeed, there is a strong argument for extending the use of prophylactic antibiotics effective against MRSA to all high-risk groups, such as patients in residential care. However, there is evidence from trials in cardiac surgery which suggests that vancomycin, an alternative glycopeptide antibiotic to teicoplanin, results in little or no decrease in the overall rates of SSI compared with cephalosporin antibiotics. 18, 19 Also, clinicians should consider the long-term consequences of increased use of vancomycin and teicoplanin in terms of the development of MRSA resistance to these agents. It has been suggested that the Department of Health's mandatory MRSA screening policy is unethical, as it will provide no benefit to the majority of patients who are screened. 8 Our study suggests that screening in elective orthopaedic surgery provides real benefits, as it allows the antibiotic prophylaxis to be altered to cover the MRSA pathogen if a patient has been previously colonised with MRSA.
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We believe that patients who screen positive for MRSA need to be informed that their risk of subsequent deep sepsis following lower-limb joint replacement surgery may be significantly increased, despite satisfactory eradication therapy prior to surgery and that, should infection develop, MRSA is likely to be the causative organism. The consequence of SSI for these patients is serious, with the subsequent readmission to hospital, wound debridement, prolonged antibiotic use and possibly delayed reconstruction. 7 Consideration should also be given to altering antibiotic prophylaxis to an MRSA-sensitive agent in all orthopaedic patients who have previously been MRSApositive, regardless of 'effective' eradication therapy.
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